Cardiff Oncology, Inc. (CRDF) has 20 known insider and institutional holders on record. The largest holder is Hunter Robert Merrill with 4,000,000 shares. Other notable holders include RA CAPITAL MANAGEMENT, L.P. and BRIDGER MANAGEMENT, LLC.
Over the last 12 months, insiders have made 12 transactions in CRDF stock — 10 buys (valued at $3.05M) and 0 sells (valued at RSU Award). Insider buying has outpaced selling during this period, which may signal confidence in the company's prospects.
CRDF Insider Ownership
Top Holder
Hunter Robert Merrill
4,000,000 shares
Buys (12 mo)
10
$3.05M value
Sells (12 mo)
0
$0.00 value
12-Month Transaction Activity
Top Insider Holders
| # |
Name |
Role |
Shares Owned |
Last Filed |
Relative Size |
| 1 |
Hunter Robert Merrill |
10 Percent Owner |
4,000,000 |
2012-04-16 |
|
| 2 |
Ra Capital Management, L.p. |
10 Percent Owner |
3,290,000 |
2020-10-02 |
|
| 3 |
Bridger Management, Llc |
Officer |
2,968,115 |
2016-11-15 |
|
| 4 |
Erlander Mark |
Chief Executive Officer |
2,925,098 |
2025-03-13 |
|
| 5 |
Schuh Antonius |
CEO |
1,858,333 |
2016-01-06 |
|
| 6 |
Pace Gary W |
Director |
1,330,676 |
2025-07-31 |
|
| 7 |
Levine James E. |
Chief Financial Officer |
1,295,117 |
2025-03-13 |
|
| 8 |
Lindsay Brigitte Ute |
Chief Accounting Officer |
1,025,334 |
2026-02-18 |
|
| 9 |
Smeal Tod |
Chief Scientific Officer |
979,805 |
2025-03-13 |
|
| 10 |
Mohindru Mani |
Chief Executive Officer |
968,766 |
2026-04-02 |
|
| 11 |
Kabbinavar Fairooz |
Chief Medical Officer |
780,008 |
2025-03-13 |
|
| 12 |
Kelemen Vicki |
Exec. VP and COO |
698,304 |
2023-03-16 |
|
| 13 |
Posard Matthew L. |
Chief Commercial Officer |
650,000 |
2016-01-06 |
|
| 14 |
Cerrone Gabriel |
Officer |
528,844 |
2013-07-29 |
|
| 15 |
Adams Thomas Phd |
Officer |
477,870 |
2021-06-14 |
|
| 16 |
Sheinerman Kira |
Director |
454,546 |
2008-08-14 |
|
| 17 |
Ruffner Katherine L |
Chief Medical Officer |
370,016 |
2022-03-10 |
|
| 18 |
Markin Rodney S |
Director |
222,865 |
2025-06-30 |
|
| 19 |
Armitage James O |
Director |
187,539 |
2025-06-27 |
|
| 20 |
Billings Paul |
Director |
175,658 |
2018-01-25 |
|
Recent Transactions (last 12 months)
| Date |
Name |
Role |
Type |
Shares |
Price |
Value |
| 2026-03-31 |
Mohindru Mani |
Chief Executive Officer |
RSU Award |
600,000 |
$1.62 |
$972K |
| 2026-02-13 |
Lindsay Brigitte Ute |
Chief Accounting Officer |
RSU Award |
200,000 |
$1.60 |
$320K |
| 2026-02-17 |
Mohindru Mani |
Interim CEO |
RSU Award |
200,000 |
$1.56 |
$312K |
| 2026-01-27 |
Lindsay Brigitte Ute |
Chief Accounting Officer |
Unknown |
166,320 |
$3.58 |
$595.43K |
| 2025-07-30 |
Pace Gary W |
Director |
Informative Buy |
275,000 |
$2.45 |
$673.75K |
| 2025-06-16 |
Sidhu Roger |
Chief Medical Officer |
Unknown |
600,000 |
$3.86 |
$2.32M |
| 2025-06-26 |
Mohindru Mani |
Director |
RSU Award |
40,565 |
$3.16 |
$128.19K |
| 2025-06-26 |
Tannenbaum Renee P |
Director |
RSU Award |
40,565 |
$3.16 |
$128.19K |
| 2025-06-26 |
Markin Rodney S |
Director |
RSU Award |
40,565 |
$3.16 |
$128.19K |
| 2025-06-26 |
White Lale |
Director |
RSU Award |
40,565 |
$3.16 |
$128.19K |
| 2025-06-26 |
Armitage James O |
Director |
RSU Award |
40,565 |
$3.16 |
$128.19K |
| 2025-06-26 |
Pace Gary W |
Director |
RSU Award |
40,565 |
$3.16 |
$128.19K |
